Preventing Myringotomy Closure with Topical Mitomycin C in Rats

Abstract

The purpose of this study was to determine whether mitomycin C could be used to prolong the patency of the myringotomy site in the absence of ventilation tubes in rats. We examined the effect of increased exposure time and repeat application of mitomycin C to the myringotomy site. Sixty animals were separated into 4 groups: group A had a single application of mitomycin C for 10 minutes; group B had a single application for 20 minutes; group C received 2 10-minute applications separated by 1 week; and group D received 2 applications (20 and 10 minutes) separated by 1 week. Mitomycin C and bacteriostatic saline solution were applied to the right and left myringotomy sites in each rat, respectively. Experimental ears in groups A, B, C, and D remained open for a median time of 6.5, 5.5, 6.5, and 8.5 weeks, respectively. The control ears healed within 1.5 weeks. This difference was statistically significant with P < 0.001 for each group. We conclude that mitomycin C is effective in prolonging the patency of myringotomies in rat tympanic membranes. Increased exposure time or repeat application of mitomycin C did not statistically alter the patency rate.

Get full access to this article

View all access options for this article.

References

Bluestone

. Complications and sequelae of nonsurgical and surgical management of otitis media. Pediatrics 1983;71:642–3.

Paradise

. On tympanostomy tubes: Rationale, results, reservations, and recommendations. Pediatrics 1977;60:86–90.

Stickler

. The attack on the tympanic membrane. Pediatrics 1984;74:291–2.

Freeman

Fireman

. Evaluation of ventilation tubes and myringotomy in the treatment of recurrent and persistent otitis media. Pediatr Infect Dis J 1991;10:2–11.

Mandel

Rockette

Bluestone

et al. Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Pediatr Infect Dis J 1992;11:270–7.

Goode

. Long-term middle ear ventilation with T tubes: The perforation problem. Otolaryngol Head Neck Surg 1996;115:500–1.

Luxford

Sheehy

. Myringotomy and ventilation tubes: A report of 1,568 ears. Laryngoscope 1982;92:1293–9.

Gates

Avery

Prihoda

et al. Delayed onset post-tympanostomy otorrhea. Otolaryngol Head Neck Surg 1988;98:111–5.

Buckingham

. Cholesteatoma and chronic otitis media following middle ear intubation. Laryngoscope 1981;91:1450–6.

10.

Lildholdt

. Ventilation tube in secretory otitis media. Acta Otolaryngol Suppl (Stockh) 1983;398:1–28.

11.

Wilpizeski

Maioriello

Reddy

et al. Otological applications of lasers: Basic background. Trans Pa Acad Ophthalmol Otolaryngol 1977;30:185–92.

12.

Soderberg

Hellstrom

Stenfors

. Myringotomy made by CO₂ laser—an alternative to ventilation tubes? An experimental study. Acta Otolaryngol (Stockh) 1984;97:335–41.

13.

DeRowe

Ophir

Katzir

. Experimental study of CO₂ laser myringotomy with a hand held otoscope and fiberoptic delivery system. Lasers Surg Med 1994;15:248–53.

14.

Goode

. CO₂ laser myringotomy. Laryngoscope 1982;92:420–3.

15.

Silverstein

Kuhn

Chao

et al. Laser-assisted tympanostomy. Laryngoscope 1996;106:1067–74.

16.

Kupin

Juzych

Shin

et al. Adjunctive mitomycin C in primary trabeculectomy in phakic eyes. Am J Ophthalmol 1995;119:30–9.

17.

Magevand

Salmon

Scholtz

et al. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 1995;102:84–90.

18.

Costa

Spaeth

Eiferman

et al. Wound healing modulation in glaucoma filtration surgery. Ophthalmic Surg 1993;3:152–70.

19.

Verweij

Pinedo

. Mitomycin C: Mechanism of action, usefulness, and limitations. Anticancer Drugs 1990;1:5–13.

20.

Koba

. Epidermal cell migration and healing of the tympanic membrane: An immunohistochemical study of cell proliferation using bromodeoxyuridine labeling. Ann Otol Rhinol Laryngol 1995;104:218–25.

21.

Armstrong

. A new treatment for chronic secretory otitis media. Arch Otolaryngol 1954;59:653–4.